Twenty-four-hour monitoring of intragastric acidity: Comparison between lansoprazole 30 mg and pantoprazole 40 mg

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 2, 1997, Pages 195-200

  Florent, Christian ^a   Forestier, Sylvie ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Takeda Laboratories   (France)

Author keywords

Gastric acid secretion; Intragastric pH monitoring; Lansoprazole; Pantoprazole

Indexed keywords

LANSOPRAZOLE; PANTOPRAZOLE; STOMACH SECRETION INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH;

EID: 0031048267     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199702000-00017     Document Type: Article

References (15)

1. Hunt RH: The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995, 9(suppl. 1):3-7.
2. Hartmann M, Theiss U, Bliesath H, et al.: Comparison of the 24-h intragastric pH profiles following single and repeated oral intake of pantoprazole 40 mg and omeprazole 20 mg in healthy male volunteers. Gastroenterology 1993, 104:A95.
3. Bruley des Varannes S, Levy P, Lartigues S, et al.: Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994, 8:309-314.
4. Florent Ch, Akrour O, Joubert M: Comparison of the effects of lansoprazole and omeprazole on gastric pH profile in healthy volunteers. Gastroenterology 1993, 104:A79.
5. Bell NJ, Burget D, Howden C, et al.: Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1993, 51(suppl. 1):59-67.
6. Lanzon-Miller S, Pounder RE, Hamilton MR, et al.: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine and omeprazole. Aliment Pharmacol Ther 1987, 1:239-251.
7. Burget DW, Stephen G, Chiverton SG, Hunt RH: Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990, 99:345-351.
8. Jones DB, Howden CW, Burget DW, et al.: Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987, 28:1120-1127.
9. Hunt RH: pH and Hp-gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. Am J Gastroenterol 1993, 88:481-483.
10. Hannan A, Weil J, Broom C, Walt RP: Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Aliment Pharmacol Ther 1992, 6:373-380.
11. Müssig S, Witzel L: Steady state intragastric pH profile after 40 mg pantoprazole: comparison of morning and evening administration. Gastroenterology 1993, 104:A154.
12. Tolman KG: Gastric pH levels after 15mg and 30mg of lansoprazole and 20mg omeprazole. Gastroenterology 1994, 106:A197.
13. 2 receptor antagonist ranitidine on intragastric pH in healthy human subjects. Gastroenterology 1995, 108:A240.
14. Simon B, Müller P, Marinis E, et al.: Effect of repeated oral administration of By1023/SKF92022, a new substituted benzimidazole derivative, on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990, 4:373-379.
15. Dammann HG, Von Zur Mühlen Balks HJ, Damaschke A, et al.: The effects of lansoprazole 30 or 60 mg daily, on intragastric pH and on endocrine function in healthy volunteers. Aliment Pharmacol Ther 1993, 7:191-196.